This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kelly, J. U. Search for Related Content PubMed Articles by Kelly, J. U. Social Bookmarking                         What's this?

The Use of an Investigational Radiopharmaceutical in Neuroblastoma: A Nursing Perspective

James Whitcomb Riley Hospital for Children, Indianapolis, IN

Children with advanced-stage neuroblastoma usually have a poor prognosis. While conventional treatment with surgery, chemotherapy, and radiation may provide some palliation, long-term survival is rare. A number of investigational therapies are being performed nationwide in an attempt to improve the progno sis for children with neuroblastoma. One such treatment is the use of ¹³¹I- metaiodobenzylguanidine. This article will review the pathophysiology of neuro blastoma, give an overview of this investigational treatment, and discuss the nursing care associated with radioactive treatment.

Journal of Pediatric Oncology Nursing, Vol. 6, No. 4, 133-138 (1989)
DOI: 10.1177/104345428900600405


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?